-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017234-wagner-final-report-2011.pdf
January 01, 2011 - Cancer patients report that a self-monitoring system that sends notices to healthcare
clinicians based … prospective study on use, appreciation and
effectiveness of an information system in head and
neck cancer
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/mvp/modules/technical/ltvv-mvpguide.pdf
January 01, 2017 - Impact of
intraoperative lung-protective interventions in
patients undergoing lung cancer surgery. … Does a protective
ventilation strategy reduce the risk of pulmonary
complications after lung cancer
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/evidence-based-reports/nutrtp4.pdf
February 01, 2012 - The Alpha-Tocopherol, Beta-Carotene
Cancer Prevention Study. … Risks and benefits of omega 3 fats for
mortality, cardiovascular disease, and
cancer: systematic review
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/osteoporosis-screening
January 14, 2025 - They do not apply to persons with secondary osteoporosis due to an underlying medical condition (eg, cancer … It does not apply to persons with secondary osteoporosis due to an underlying medical condition (eg, cancer
-
hcup-us.ahrq.gov/reports/statbriefs/sb239-Opioid-Payer-Hospital-Stays-ED-Visits-by-State.pdf
February 01, 2018 - The NIS includes obstetrics and gynecology, otolaryngology, orthopedic,
cancer, pediatric, public, and … Community hospitals include obstetrics and gynecology, otolaryngology,
orthopedic, cancer, pediatric
-
effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-summary.pdf
April 01, 2020 - Control and Prevention in the United States and
the Canadian Guideline for Opioid Use in Chronic
Non-Cancer … The 2017 Canadian
Guideline for Opioids for Chronic Non-Cancer pain.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/KdQef_VDT2kmHDX4ddNWmR
August 01, 2022 - , persons living with HIV, patients receiving immunosuppressive
medications such as chemotherapy or tumor … infec-
tion, risk factors increasing risk of progression to active disease (such
as diabetes, lupus, cancer … , alcoholism, and drug addiction), use of
immune-suppressing drugs such as tumor necrosis factor inhibi
-
www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/projects/state/how-to-guide/how-to-guide.pdf
August 01, 2024 - Population
Health Consortium, which is similarly working to improve primary care by focusing on diabetes, cancer … Improvement Program
for rural health
• Health topic–specific QI initiatives such as Million Hearts®, Cancer … millionhearts.hhs.gov/about-million-hearts/index.html
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative … providing grants, technical assistance, and resources supporting quality patient care
(e.g., American Cancer
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_disposition-comments.pdf
May 13, 2014 - TEP
Reviewer
#1
Introduction
(and ES)
P ES-1 & p2: Include cancers associated with AUD in listed … We have added the most common cancers
associated with AUDs to this list in the full report. … We did not add it to the ES because we want to
keep it as concise as possible (we do have “cancer”
-
hcup-us.ahrq.gov/db/nation/nass/stats/nass_summary_stats_dx_pr_grps_weighted_2021.pdf
January 01, 2021 - 1650 Leukemia
551 CMR_CANCER_LYMPH Num 3 1647 Lymphoma
553 CMR_CANCER_METS Num 3 1653 Metastatic cancer … 554 CMR_CANCER_NSITU Num 3 1656 Solid tumor without metastasis, in situ
555 CMR_CANCER_SOLID Num 3 … 1659 Solid tumor without metastasis, malignant
556 CMR_DEMENTIA Num 3 1662 Dementia
557 CMR_DEPRESS … Infectious and Parasitic Diseases 8,896,507 0 0 1 170,765 3,731.18 163,449.08 178,081.33
3 DXCCSR_NEOnnn Neoplasms … Diseases of the Musculoskeletal System and Connective Tissue 2,367,353 19.87% 9,640,502 80.90%
NEOnnn: Neoplasms
-
hcup-us.ahrq.gov/db/nation/nass/stats/nass_summary_stats_dx_pr_grps_unweighted_2021.pdf
January 01, 2021 - 1650 Leukemia
551 CMR_CANCER_LYMPH Num 3 1647 Lymphoma
553 CMR_CANCER_METS Num 3 1653 Metastatic cancer … 554 CMR_CANCER_NSITU Num 3 1656 Solid tumor without metastasis, in situ
555 CMR_CANCER_SOLID Num 3 … 1659 Solid tumor without metastasis, malignant
556 CMR_DEMENTIA Num 3 1662 Dementia
557 CMR_DEPRESS … DXCCSR_INFnnn : Certain Infectious and Parasitic Diseases 8,896,507 0 0 1 0.0 125,386
DXCCSR_NEOnnn : Neoplasms … Diseases of the Musculoskeletal System and Connective Tissue 1,757,356 19.75% 7,175,583 80.66%
NEOnnn: Neoplasms
-
hcup-us.ahrq.gov/db/nation/nass/stats/NASS_Summary_Stats_DX_PR_GRPS_Weighted_2022.pdf
January 01, 2022 - CMR_CANCER_LEUK Num 3 18 Leukemia
7 CMR_CANCER_LYMPH Num 3 21 Lymphoma
8 CMR_CANCER_METS Num 3 24 Metastatic cancer … 9 CMR_CANCER_NSITU Num 3 27 Solid tumor without metastasis, in situ
10 CMR_CANCER_SOLID Num 3 30 Solid … tumor without metastasis, malignant
11 CMR_DEMENTIA Num 3 33 Dementia
12 CMR_DEPRESS Num 3 36 Depression … Infectious and Parasitic Diseases 9097088 0 0 1.000000 0.013669 0.000204 169235 3496.118530
DXCCSR_NEOnnn Neoplasms … 0.17%
MUSnnn: Diseases of the Musculoskeletal System and Connective Tissue 2,580,325 20.84%
NEOnnn: Neoplasms
-
hcup-us.ahrq.gov/db/nation/nass/stats/nass_summary_stats_dx_pr_grps_unweighted_2019.pdf
January 01, 2019 - CMR_CANCER_LEUK Num 3 18 Leukemia
8 CMR_CANCER_LYMPH Num 3 21 Lymphoma
9 CMR_CANCER_METS Num 3 24 Metastatic cancer … 10 CMR_CANCER_NSITU Num 3 27 Solid tumor without metastasis, in situ
11 CMR_CANCER_SOLID Num 3 30 … Solid tumor without metastasis, malignant
12 CMR_DEMENTIA Num 3 33 Dementia
13 CMR_DEPRESS Num 3 36 … DXCCSR_INFnnn : Certain Infectious and Parasitic Diseases 8,994,101 0 0 1 0.0 122,625
DXCCSR_NEOnnn : Neoplasms … Diseases of the Musculoskeletal System and Connective Tissue 1,411,117 15.69% 7,113,388 79.09%
NEOnnn: Neoplasms
-
hcup-us.ahrq.gov/db/nation/nass/stats/nass_summary_stats_dx_pr_grps_weighted_2020.pdf
January 01, 2020 - CMR_CANCER_LEUK Num 3 21 Leukemia
6 CMR_CANCER_LYMPH Num 3 18 Lymphoma
8 CMR_CANCER_METS Num 3 24 Metastatic cancer … 9 CMR_CANCER_NSITU Num 3 27 Solid tumor without metastasis, in situ
10 CMR_CANCER_SOLID Num 3 30 Solid … tumor without metastasis, malignant
11 CMR_DEMENTIA Num 3 33 Dementia
12 CMR_DEPRESS Num 3 36 Depression … Infectious and Parasitic Diseases 7,828,310 0 0 1 151,573 3,197.40 145,303.14 157,842.06
3 DXCCSR_NEOnnn Neoplasms … Diseases of the Musculoskeletal System and Connective Tissue 1,887,746 18.26% 8,293,117 80.22%
NEOnnn: Neoplasms
-
hcup-us.ahrq.gov/db/nation/nass/stats/nass_summary_stats_dx_pr_grps_weighted_2019.pdf
January 01, 2019 - CMR_CANCER_LEUK Num 3 18 Leukemia
8 CMR_CANCER_LYMPH Num 3 21 Lymphoma
9 CMR_CANCER_METS Num 3 24 Metastatic cancer … 10 CMR_CANCER_NSITU Num 3 27 Solid tumor without metastasis, in situ
11 CMR_CANCER_SOLID Num 3 30 … Solid tumor without metastasis, malignant
12 CMR_DEMENTIA Num 3 33 Dementia
13 CMR_DEPRESS Num 3 36 … Infectious and Parasitic Diseases 8,994,101 0 0 1 163,720 3,936.33 156,001.22 171,437.80
3 DXCCSR_NEOnnn Neoplasms … Diseases of the Musculoskeletal System and Connective Tissue 1,875,420 15.79% 9,424,067 79.32%
NEOnnn: Neoplasms
-
hcup-us.ahrq.gov/db/nation/nass/stats/nass_summary_stats_dx_pr_grps_unweighted_2020.pdf
January 01, 2020 - CMR_CANCER_LEUK Num 3 21 Leukemia
6 CMR_CANCER_LYMPH Num 3 18 Lymphoma
8 CMR_CANCER_METS Num 3 24 Metastatic cancer … 9 CMR_CANCER_NSITU Num 3 27 Solid tumor without metastasis, in situ
10 CMR_CANCER_SOLID Num 3 30 Solid … tumor without metastasis, malignant
11 CMR_DEMENTIA Num 3 33 Dementia
12 CMR_DEPRESS Num 3 36 Depression … DXCCSR_INFnnn : Certain Infectious and Parasitic Diseases 7,828,310 0 0 1 0.0 113,194
DXCCSR_NEOnnn : Neoplasms … Diseases of the Musculoskeletal System and Connective Tissue 1,420,778 18.15% 6,260,728 79.98%
NEOnnn: Neoplasms
-
effectivehealthcare.ahrq.gov/health-topics/malnutrition
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1412.pdf
October 01, 2015 - patient acceptance.43 Payers are likely to cover both drugs
because IPF has a worse prognosis than some cancers … estimated to cost about $40,000 annually at the time of expert comment, which is less than many
cancer
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/outcomes/chipra-140-fullreport.pdf
November 02, 2017 - Parent and physician perspectives on quality of care at
the end of life in children with cancer. … Improving physician-patient communication about
cancer pain with a tailored education-coaching intervention … Using patients’ experiences to identify priorities for quality improvement in breast cancer care:
patient
-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2010.jsp
January 01, 2010 - The NIS' large sample size enables analyses of rare conditions, such as specific types of cancer; uncommon … Discharged/transferred to an Intermediate Care Facility (ICF), (5) Discharged/transferred to a Designated Cancer … present, (1) Comorbidity is present
CM_METS
2002-2010
AHRQ comorbidity measure: Metastatic cancer … not present, (1) Comorbidity is present
CM_TUMOR
2002-2010
AHRQ comorbidity measure: Solid tumor … Chronic condition indicator body system for all diagnoses: (1) Infectious and parasitic disease, (2) Neoplasms